Hybridon, Roche deal

The companies selected a lead compound, HYB 101400 hybrid antisense

Read the full 108 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE